Partial Trisomy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Gene dosage effect for human triosephosphate isomerase and glyceraldehyde-3-phosphate dehydrogenase in partial trisomy 12p13 and trisomy 18p.
|
730182 |
1978 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
With 40 cycles of amplification, dissected stromal and tumor tissue both yielded products encoding glyceraldehyde 3'-phosphate dehydrogenase but only the tumor cells gave products with primers specific for either keratin 19, heat shock protein 89 alpha or the fig oncogene, which encodes one of the fibroblast growth factor receptors that we have recently found to be expressed in breast cancers.
|
1378704 |
1992 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
With 40 cycles of amplification, dissected stromal and tumor tissue both yielded products encoding glyceraldehyde 3'-phosphate dehydrogenase but only the tumor cells gave products with primers specific for either keratin 19, heat shock protein 89 alpha or the fig oncogene, which encodes one of the fibroblast growth factor receptors that we have recently found to be expressed in breast cancers.
|
1378704 |
1992 |
Anemia, Sickle Cell
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased membrane activity of glyceraldehyde 3-phosphate dehydrogenase in erythrocytes of patients with homozygous sickle cell anaemia.
|
1395049 |
1992 |
Hodgkin Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this work, the most reliable housekeeping gene for gene expression analysis of Hodgkin's disease (HD) lymph nodes was determined by comparing the conventional housekeeping genes, beta-actin, beta-tubulin, GAPDH, and the mouse gene LLRep3, that had been used previously in gene expression studies.
|
1774960 |
1991 |
Neuroblastoma
|
0.080 |
AlteredExpression
|
disease |
BEFREE |
When the relative ratio of the smg-25A mRNA level to the glyceraldehyde-3-phosphate dehydrogenase mRNA level was compared among neuroblastoma tumor tissues, the value was significantly higher in tumors histologically diagnosed as ganglioneuroblastoma.
|
2121331 |
1990 |
Central neuroblastoma
|
0.080 |
AlteredExpression
|
disease |
BEFREE |
When the relative ratio of the smg-25A mRNA level to the glyceraldehyde-3-phosphate dehydrogenase mRNA level was compared among neuroblastoma tumor tissues, the value was significantly higher in tumors histologically diagnosed as ganglioneuroblastoma.
|
2121331 |
1990 |
Childhood Neuroblastoma
|
0.080 |
AlteredExpression
|
disease |
BEFREE |
When the relative ratio of the smg-25A mRNA level to the glyceraldehyde-3-phosphate dehydrogenase mRNA level was compared among neuroblastoma tumor tissues, the value was significantly higher in tumors histologically diagnosed as ganglioneuroblastoma.
|
2121331 |
1990 |
Ganglioneuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
When the relative ratio of the smg-25A mRNA level to the glyceraldehyde-3-phosphate dehydrogenase mRNA level was compared among neuroblastoma tumor tissues, the value was significantly higher in tumors histologically diagnosed as ganglioneuroblastoma.
|
2121331 |
1990 |
Childhood Ganglioneuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
When the relative ratio of the smg-25A mRNA level to the glyceraldehyde-3-phosphate dehydrogenase mRNA level was compared among neuroblastoma tumor tissues, the value was significantly higher in tumors histologically diagnosed as ganglioneuroblastoma.
|
2121331 |
1990 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
When stably transfected and expressed in 3T3-F442A preadipocytes and H35 hepatoma cells, the intact human GAPDH gene is induced 10-fold by insulin in 3T3-F442A adipocytes and 3-fold by insulin in H35 hepatoma lines, which is similar to the induction obtained with the endogenous gene.
|
2839830 |
1988 |
Liver neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
When stably transfected and expressed in 3T3-F442A preadipocytes and H35 hepatoma cells, the intact human GAPDH gene is induced 10-fold by insulin in 3T3-F442A adipocytes and 3-fold by insulin in H35 hepatoma lines, which is similar to the induction obtained with the endogenous gene.
|
2839830 |
1988 |
Malignant neoplasm of lung
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
Similarity between glyceraldehyde-3-phosphate dehydrogenase and a 37,000-dalton protein which is abundantly expressed in human lung cancers.
|
3089988 |
1986 |
Carcinogenesis
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
These results suggest a possible involvement of GAPDH itself or a GAPDH-related protein in lung tumorigenesis.
|
3089988 |
1986 |
Lung Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Tryptic peptide mapping analysis showed that the pattern of 37K was very similar to those of GAPDHs both purified from lung tumor and obtained commercially.
|
3089988 |
1986 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Levels of GAPDH protein were elevated in nude mouse tumors and fresh human pancreatic adenocarcinomas compared to normal pancreas.
|
3180054 |
1988 |
Adenocarcinoma
|
0.030 |
AlteredExpression
|
group |
BEFREE |
High GAPDH levels may be characteristic of human adenocarcinomas, since colon adenocarcinomas also exhibited high levels of GAPDH compared to normal colon.
|
3180054 |
1988 |
Adenocarcinoma of pancreas
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
|
3180054 |
1988 |
Malignant neoplasm of lung
|
0.090 |
Biomarker
|
disease |
BEFREE |
The structure of the lung cancer GAPDH is identical to that of liver GAPDH.
|
3664468 |
1987 |
Carcinoma of lung
|
0.090 |
Biomarker
|
disease |
BEFREE |
The structure of the lung cancer GAPDH is identical to that of liver GAPDH.
|
3664468 |
1987 |
Primary malignant neoplasm of lung
|
0.080 |
Biomarker
|
disease |
BEFREE |
The structure of the lung cancer GAPDH is identical to that of liver GAPDH.
|
3664468 |
1987 |
Prostate carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12) activity and mRNA content is altered in the androgen-responsive human prostate carcinoma cell line LNCaP after exposure to the synthetic androgen R1881.
|
7671226 |
1995 |
Alzheimer's Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The possible localization of Gapdh on MMU16--which may provide a mouse model for Down's syndrome and Alzheimer's disease--may lead to new insights into glycolysis and its role in the two syndromes.
|
7891898 |
1994 |
Down Syndrome
|
0.030 |
Biomarker
|
disease |
BEFREE |
The possible localization of Gapdh on MMU16--which may provide a mouse model for Down's syndrome and Alzheimer's disease--may lead to new insights into glycolysis and its role in the two syndromes.
|
7891898 |
1994 |
Complete Trisomy 21 Syndrome
|
0.030 |
Biomarker
|
disease |
BEFREE |
The possible localization of Gapdh on MMU16--which may provide a mouse model for Down's syndrome and Alzheimer's disease--may lead to new insights into glycolysis and its role in the two syndromes.
|
7891898 |
1994 |